Arsenal Biosciences

Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson

Andrew Huberman

A company co-founded based on technology from Dr. Marson's lab, now in clinical trials for solid tumors (e.g., prostate cancer) using CRISPR-engineered CAR T-cells with enhanced resilience.